Donald W. Combs

851 total citations
32 papers, 706 citations indexed

About

Donald W. Combs is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Donald W. Combs has authored 32 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 16 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Donald W. Combs's work include Estrogen and related hormone effects (7 papers), Synthesis and Biological Evaluation (7 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (6 papers). Donald W. Combs is often cited by papers focused on Estrogen and related hormone effects (7 papers), Synthesis and Biological Evaluation (7 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (6 papers). Donald W. Combs collaborates with scholars based in United States, Germany and Sweden. Donald W. Combs's co-authors include A. Phillips, Philip J. Rybczynski, Keith T. Demarest, John B. Moore, Robert Falotico, Khehyong Ngu, Dieter H. Klaubert, Stanley C. Bell, David S. Weinstein and Frank M. Hauser and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Biochemical Pharmacology.

In The Last Decade

Donald W. Combs

32 papers receiving 667 citations

Peers

Donald W. Combs
Charles W. Lugar United States
Zhang B. Xu United States
Seung Kyu Kang South Korea
Jeffery S. Carter United States
Jane L. Wang United States
Donald W. Combs
Citations per year, relative to Donald W. Combs Donald W. Combs (= 1×) peers Sigfrid Schwarz

Countries citing papers authored by Donald W. Combs

Since Specialization
Citations

This map shows the geographic impact of Donald W. Combs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald W. Combs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald W. Combs more than expected).

Fields of papers citing papers by Donald W. Combs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald W. Combs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald W. Combs. The network helps show where Donald W. Combs may publish in the future.

Co-authorship network of co-authors of Donald W. Combs

This figure shows the co-authorship network connecting the top 25 collaborators of Donald W. Combs. A scholar is included among the top collaborators of Donald W. Combs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald W. Combs. Donald W. Combs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngu, Khehyong, David S. Weinstein, Wen Liu, et al.. (2011). Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase. Bioorganic & Medicinal Chemistry Letters. 21(14). 4141–4145. 30 indexed citations
2.
Weinstein, David S., Wen Liu, Khehyong Ngu, et al.. (2007). Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: Highly potent against human enzyme within a cellular environment. Bioorganic & Medicinal Chemistry Letters. 17(18). 5115–5120. 47 indexed citations
3.
Weinstein, David S., Wen Liu, Zhengxiang Gu, et al.. (2005). Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase. Bioorganic & Medicinal Chemistry Letters. 15(5). 1435–1440. 46 indexed citations
4.
Chen, Robert H., Keith T. Demarest, Joseph W. Gunnet, et al.. (2004). Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists. Bioorganic & Medicinal Chemistry Letters. 14(12). 3143–3146. 4 indexed citations
5.
Chen, Robert H., Keith T. Demarest, Joseph W. Gunnet, et al.. (2004). Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(11). 2987–2989. 10 indexed citations
6.
Ahmad, Saleem, Khehyong Ngu, Donald W. Combs, et al.. (2003). Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1. Bioorganic & Medicinal Chemistry Letters. 14(1). 177–180. 18 indexed citations
7.
Rybczynski, Philip J., Donald W. Combs, Ignatius J. Turchi, et al.. (2003). Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions. Bioorganic & Medicinal Chemistry Letters. 13(14). 2359–2362. 16 indexed citations
8.
Palmer, Stephen, Carolyn A. Campen, George F. Allan, et al.. (2000). Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity. The Journal of Steroid Biochemistry and Molecular Biology. 75(1). 33–42. 44 indexed citations
10.
Allan, George F., Donna Haynes‐Johnson, Susan Palmer, et al.. (1996). Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail.. Molecular Endocrinology. 10(10). 1206–1213. 22 indexed citations
11.
Combs, Donald W., et al.. (1995). Nonsteroidal progesterone receptor ligands. 1. 3-Aryl-1-benzoyl-1,4,5,6- tetrahydropyridazines.. Journal of Medicinal Chemistry. 38(25). 4878–4879. 64 indexed citations
12.
Combs, Donald W., et al.. (1995). Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors. Journal of Medicinal Chemistry. 38(25). 4880–4884. 48 indexed citations
13.
Combs, Donald W.. (1995). Review Oncologic, Endocrine & Metabolic: Recent developments in aromatase inhibitors. Expert Opinion on Therapeutic Patents. 5(6). 529–533. 4 indexed citations
14.
Combs, Donald W., et al.. (1992). Heteroatom analogs of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones. Journal of Medicinal Chemistry. 35(1). 172–176. 16 indexed citations
15.
Combs, Donald W., et al.. (1991). Bemoradan—a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue. Biochemical Pharmacology. 42(3). 679–683. 9 indexed citations
16.
Combs, Donald W., et al.. (1991). 2-aryl-1,2-dihydro-6,7-dimethoxyquinazoline-3-oxides with positive inotropic activity. Bioorganic & Medicinal Chemistry Letters. 1(2). 133–136. 2 indexed citations
17.
Combs, Donald W., Stanley C. Bell, Dieter H. Klaubert, et al.. (1990). 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents. Journal of Medicinal Chemistry. 33(1). 380–386. 86 indexed citations
18.
Combs, Donald W., Ronald K. Russell, Richard Rampulla, et al.. (1990). Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides.. PubMed. 6(4). 241–54. 7 indexed citations
19.
Hauser, Frank M., et al.. (1983). Aklavin-type anthracyclinones: brief, regioispecific syntheses of tetracyclic intermediates. The Journal of Organic Chemistry. 48(8). 1328–1333. 21 indexed citations
20.
Furusawa, Eiichi, Hiroshi Irie, Donald W. Combs, & W. C. Wildman. (1980). Therapeutic Activity of Pretazettine on Rauscher Leukemia: Comparison with the Related Amaryllidaceae Alkaloids. Chemotherapy. 26(1). 36–45. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026